DGPharma
0508.925.544 · rovalta.com · 22/09/2026
ACTIVE
DGPharma
Financial year 2024 · closed on 31/12/2024
Net result
65,3 k €
+9.2% YoY
Gross margin
94,1 k €
-39.5% YoY
Equity
571,8 k €
+12.9% YoY
Overview
What does DGPharma do?
DGPharma is a Private limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0508.925.544
Incorporation
28/12/2012
Legal form
Private limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
9051 Gent · FlandreSee on map
Contributed capital
300 000,00 €
Latest accounts
31/12/2024
Activities (NACE)
46460Wholesale of pharmaceutical goods· main47279Retail sale of food, beverages and tobacco in specialised stores47299Other retail sale of food in specialised stores46389Wholesale of other food, including fish, crustaceans and molluscs46389Wholesale of other food, including fish, crustaceans and molluscs70200Management consultancy activities+1
Joint committees (1)
- 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 11 financial years
| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||
| Gross margin | 94,1 k € | -39.5% | 155,5 k € | +45.1% | 107,2 k € | -29.8% | 152,8 k € | +50.6% | 101,5 k € | +95.2% | 52 k € | +181% | -64 k € | -411% | 20,6 k € | -53.2% | 44 k € | -30.0% | 62,8 k € | +298% | -31,7 k € |
| EBITDA | 91 k € | -21.3% | 115,7 k € | +10.6% | 104,5 k € | -11.7% | 118,3 k € | +29.8% | 91,1 k € | +76.0% | 51,8 k € | +156% | -92,4 k € | -20961% | 442,8 € | -99.0% | 43,6 k € | -30.2% | 62,4 k € | +295% | -32 k € |
| Operating result | 95,8 k € | +4.8% | 91,4 k € | -10.0% | 101,6 k € | -26.6% | 138,5 k € | +83.7% | 75,4 k € | +51.5% | 49,8 k € | +153% | -94,4 k € | -21413% | 442,8 € | -99.0% | 43,6 k € | -30.2% | 62,4 k € | +295% | -32 k € |
| Net result | 65,3 k € | +9.2% | 59,8 k € | -10.0% | 66,4 k € | -41.8% | 114,1 k € | +71.4% | 66,6 k € | +108% | 32 k € | +129% | -109,4 k € | -704% | -13,6 k € | -177% | 17,6 k € | -63.1% | 47,7 k € | +224% | -38,6 k € |
| Balance sheet | |||||||||||||||||||||
| Equity | 571,8 k € | +12.9% | 506,5 k € | +13.4% | 446,7 k € | +17.5% | 380,3 k € | +25.8% | 302,4 k € | +28.2% | 235,8 k € | +15.7% | 203,7 k € | +223% | 63,2 k € | -17.7% | 76,8 k € | +29.8% | 59,1 k € | +418% | 11,4 k € |
| Total assets | 1,3 M € | -4.9% | 1,4 M € | +40.3% | 1 M € | +43.0% | 704,6 k € | +63.0% | 432,3 k € | +9.9% | 393,3 k € | +20.8% | 325,5 k € | +50.4% | 216,4 k € | +19.7% | 180,8 k € | -11.4% | 204 k € | +68.0% | 121,4 k € |
| Cash | – | 0 € | -100% | 118,2 k € | -36.1% | 185,1 k € | +170% | 68,5 k € | +0.1% | 68,4 k € | -57.3% | 160,2 k € | +230% | 48,6 k € | +118% | 22,3 k € | -24.8% | 29,7 k € | -60.9% | 75,8 k € | |
| Debts | 772,6 k € | -14.8% | 906,7 k € | +61.6% | 560,9 k € | +72.9% | 324,3 k € | +150% | 129,8 k € | -17.6% | 157,5 k € | +38.4% | 113,8 k € | -25.7% | 153,2 k € | +47.3% | 104,1 k € | -28.2% | 144,8 k € | +31.7% | 110 k € |
| Other | |||||||||||||||||||||
| Workforce | – | 0,0 ETP | 0,0 ETP | – | – | – | – | – | – | – | – | ||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2024 · 3 active · 8 ended
Active mandates
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
b+pharma Belgium● Active | 0474.817.869 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
Ceres Pharmaceuticals● Active | 0407.326.754 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
CREDOPHAR● Active | 0849.730.193 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
KOUTERLOS● Active | 0450.036.349 |
Labophar● Active | 0643.723.177 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Annual accounts
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/07/2025 | 05/07/2024 | 31/08/2023 | 16/06/2022 | 29/06/2021 | 04/08/2020 |
| General meeting | 14/06/2025 | 08/06/2024 | 10/06/2023 | 11/06/2022 | 12/06/2021 | 31/07/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
12 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 14/06/2025 | 22/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 08/06/2024 | 05/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 10/06/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 11/06/2022 | 16/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 12/06/2021 | 29/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/07/2020 | 04/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/08/2019 | 30/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 09/06/2018 | 28/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 10/06/2017 | 14/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 11/06/2016 | 17/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 13/06/2015 | 08/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 14/06/2014 | 26/06/2014 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2024 · 3 active · 8 ended
Active mandates
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates16/11/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Registered office24/02/2023MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
- Mandates12/12/2022MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates17/07/2020ONTSLAGEN - BENOEMINGEN
- Registered office27/06/2018MAATSCHAPPELIJKE ZETEL
- Mandates29/03/2018ONTSLAGEN - BENOEMINGEN
- Registered office14/03/2018MAATSCHAPPELIJKE ZETEL
- Capital / shares14/02/2017KAPITAAL - AANDELEN - DIVERSEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202465,3 k €↑
- 2023Annual accounts 202359,8 k €↓
- 2022Annual accounts 202266,4 k €↓
- 2021Annual accounts 2021114,1 k €↑
- 2019Annual accounts 201966,6 k €↑
- 2018Annual accounts 201832 k €↑
- 2017Annual accounts 2017-109,4 k €↓
- 2016Annual accounts 2016-13,6 k €↓
- 2016Name changeDGPHARMA
- 2015Annual accounts 201517,6 k €↓
- 2014Annual accounts 201447,7 k €↑
- 2013Annual accounts 2013-38,6 k €
- 2013Name changeDGPharma Benelux
- 28/12/2012IncorporationPrivate limited company